Q2 2026 Holdings
Filed 2026-08-14 | 82 holdings | $9.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Savara Inc(SVRA) | COM | 805111101 | $83.6M | 13,569,000 | 0.9% |
| Ionis Pharmaceuticals Inc | NOTE 1.750% 6/1 | 462222AF7 | $93.1M | $60,000,000 | 1.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $97.5M | 1,615,696 | 1.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $101.2M | 2,714,503 | 1.1% |
| Alignment Healthcare Inc | NOTE 4.250%11/1 | 01625VAB0 | $103.8M | $61,000,000 | 1.1% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $106.8M | 3,958,000 | 1.1% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $108.6M | 35,606,974 | 1.1% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $109.7M | 1,125,313 | 1.1% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $113.2M | 1,389,055 | 1.2% |
| Celcuity Inc | NOTE 0.250% 8/0 | 15102KAB6 | $113.8M | $100,000,000 | 1.2% |
| Pharvaris N V(PHVS) | COM | N69605108 | $116.7M | 3,376,042 | 1.2% |
| Adapthealth Corp(AHCO) | COMMON STOCK | 00653Q102 | $119.6M | 11,477,730 | 1.2% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $131.0M | 4,190,611 | 1.4% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $133.5M | 4,520,000 | 1.4% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $144.5M | 4,264,789 | 1.5% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $151.0M | 15,096,403 | 1.6% |
| Celcuity Inc(CELC) | COM | 15102K100 | $151.8M | 1,451,014 | 1.6% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $157.0M | 1,979,669 | 1.6% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $168.1M | 3,916,400 | 1.8% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $187.2M | 11,637,032 | 2.0% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $188.6M | 6,865,000 | 2.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $193.7M | 5,006,104 | 2.0% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $235.0M | 8,137,638 | 2.5% |
| Arrowhead Pharmaceuticals in | NOTE 1/1 | 04280AAC4 | $240.5M | $200,000,000 | 2.5% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $247.6M | 457,000 | 2.6% |
| Revolution Medicines Inc | NOTE 0.500% 5/0 | 76155XAA8 | $251.7M | $200,000,000 | 2.6% |
| Centene Corp del(CNC) | COM | 15135B101 | $314.6M | 4,901,000 | 3.3% |
| Viatris Inc(VTRS) | COM | 92556V106 | $320.9M | 20,206,170 | 3.3% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $322.5M | 963,351 | 3.4% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $448.0M | 2,392,000 | 4.7% |
| Brookdale SR Living Inc | NOTE 3.500%10/1 | 112463AF1 | $585.7M | $306,885,000 | 6.1% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $2.1B | 17,248,450 | 22.2% |